A quick update on the progress of state-level psychedelics bills under discussion as of May 12:
Arizona: Gov. Katie Hobbs (D) approved appropriations bill SB 1720 including a $5 million psilocybin research funding provision and advisory council. Related SB 1726 sets specifics for psilocybin clinical trials.
Both measures passed the Senate on May 10, while the House gave initial approval to companion versions of the legislation. Full passage is expected soon, reported Marijuana Moment.
SB 1726 states that research grants will be undertaken on whole mushroom psilocybin Phase 1, 2 and 3 clinical trials for DEA authorization to target conditions like PTSD, long COVID-19, depression and anxiety disorders.
Connecticut: HB 6734 downgrading criminalization of …